The global personal mobility devices market size was valued at USD 14.9 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. The market has witnessed a decline in 2020 during the COVID-19 pandemic due to the disrupted transportation of the devices. An increasing population, growing product development, and a rising number of accidents causing disabilities are some of the key factors driving the market for personal mobility devices. The rising geriatric population and cases of chronic diseases across the globe are the major factors contributing to market growth.
The COVID-19 pandemic negatively affected the global market as the demand and production of personal mobility devices were decreased and revenues of key players took a hit owing to the pandemic. For instance, the annual revenue of Invacare fell by 8.3% in 2020. However, the implementation of proactive steps and policies has created better opportunities for the market players owing to the ease in distribution systems due to revised COVID-19 restrictions in different regions. Government initiatives such as favorable reimbursement policies, for instance, the Medicare reimbursement program for purchased and rented devices are expected to drive the market for personal mobility devices.
Few mobility devices, such as walkers, wheelchairs, canes, and crutches, are also covered under Medicare insurance Part B. The market players are also adopting various strategic initiatives such as a change in distribution footprints to reduce the transit time and freight charges. For instance, the net sales of Invacare Corporation increased by 2.6% from 2020 to 2021 owing to the cost improvement strategy in supply-chain and administrative functions and global IT modernization initiatives for optimizing the operations structure of the company.
In U.S., the personal mobility devices market, the walking aids product segment is expected to witness a CAGR of 6.1% over the forecast period. The Indian government has initiated the Scheme of Assistance to Disabled Persons to help in procuring sophisticated, durable and modern, scientifically manufactured, standard aids and medical devices to promote social, psychological, and physical rehabilitation of people with disabilities. Moreover, this provision is expected to assist in enhancing the economic potential for purchasing mobility devices. Assistive devices are given to public work departments to promote independent living and to reduce the extent of disability. Technological advancements in products are among the most important drivers for the market.
The introduction of advanced mobility scooters, transfer lifts, and automated rollators are expected to significantly improve the usage rates of mobility devices. For instance, Phoenix Instinct is the first lightweight wheelchair with smart technology which comes with a carbon fiber body and other life-enhancing features.
The wheelchair segment dominated the market for personal mobility devices and accounted for the largest revenue share of over 41.2% in 2021. The segment is expected to retain the leading position throughout the forecast period. Wheelchairs are one of the most common assistive devices used in personal mobility. United Nations provides appropriate legislation for requesting member states in supporting the development, production, distribution, and servicing of these mobility devices. The usage of appropriate wheelchairs enhances the quality of life, reduces common problems, such as deformities and pressure sores, and improves digestion and respiration.
There are approximately 2 million new users every year, which translates to increased demand for wheelchairs in the country. Powered wheelchairs emerged as the largest sub-segment, in terms of revenue, in 2021. The increasing global geriatric population, chronic diseases, and growing adoption of powered wheelchairs are the key factors responsible for the growth of the wheelchair market.
Europe dominated the market for personal mobility devices and accounted for a revenue share of 33.3% in 2021. The regional market will grow at a steady rate during the forecast years due to the increasing geriatric population, rising prevalence of age-associated diseases, presence of improved healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies for purchase or rental services.
However, in Asia Pacific, the market for personal mobility devices is expected to grow fast from 2022 to 2030. This is attributed to the increasing geriatric population in Asian countries, such as Japan, China, and India. In addition, extensive R&D activities undertaken by various organizations, such as the China Rehabilitation Research Center (CRRC), are expected to drive the regional market. Increasing disposable income levels, rising awareness, high healthcare expenditure, and government initiatives aimed at improving healthcare access are also expected to boost the market growth in Asia Pacific. The U.S. government doubled the funding for Rehabilitation Engineering Research Center programs for accelerating the research in the field of personal mobility.
The market players are focusing on adopting various growth strategies, such as partnership and expansion of product portfolio, to retain their market position. For instance, in June 2021, Rollz international launched a new Rollz Flex 2 rollator which provides better comfort, stability, and design to the user. This rollator is among the most innovative creations of the company. Some of the prominent players in the global personal mobility devices market include:
Drive DeVilbiss Healthcare
GF Health Products, Inc.
Carex Health Brands, Inc.
Kaye Products, Inc.
Medline Industries, Inc.
NOVA Medical Products
Market size value in 2022
USD 18.3 billion
Revenue forecast in 2030
USD 29.8 billion
CAGR of 6.3% from 2022 to 2030
Base year for estimation
2018 - 2020
2022 - 2030
Volume in K Units, revenue in USD million, and CAGR from 2022 to 2030
Volume forecast, revenue forecast, competitive landscape, growth factors, and trends
Product, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; France; U.K.; Germany; Italy; Spain; Netherlands; Switzerland; Sweden; Belgium; Russia; China; India; Japan; Indonesia; Malaysia; Singapore; South Korea; Thailand; Taiwan; Australia; Philippines; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt
Key companies profiled
Drive DeVilbiss Healthcare; GF Health Products, Inc.; Invacare Corporation; Carex Health Brands, Inc.; Kaye Products, Inc.; Briggs Healthcare; Medline Industries, Inc.; NOVA Medical Products; Performance Health; Rollz International
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global personal mobility devices market report based on product, end-use and region:
Product Outlook (Volume, K Units; Revenue, USD Million, 2018 - 2030)
Medical Mobility Aids & Ambulatory Devices
Medical Furniture & Bathroom Safety Products
Stand up Lifts
Heavy Duty Lifts
Overhead Track Lifts
Indoor Stair Lifts
Outdoor Stair Lifts
Bars & Railings
Commodes & Shower Chairs
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Home care Settings
Regional Outlook (Volume, K Units; Revenue, USD Million, 2018 - 2030)
b. The global personal mobility devices market size was estimated at USD 14.93 billion in 2021 and is expected to reach USD 18.35 billion in 2022.
b. The global personal mobility devices market is expected to grow at a compound annual growth rate of 6.3% from 2022 to 2030 to reach USD 29.8 billion by 2030.
b. Europe dominated the personal mobility devices market with a share of 33.2% in 2021. This is attributable to the growing prevalence of age-associated diseases, increasing geriatric population, presence of improved healthcare infrastructure, and high healthcare expenditure.
b. Some key players operating in the personal mobility devices market include Drive DeVilbiss Healthcare; GF HEALTH PRODUCTS, INC.; Invacare Corporation; Carex Health Brands, Inc.; Kaye Products, Inc.; Briggs Healthcare; Medline Industries, Inc.; NOVA Medical Products; Performance Health; and Rollz International.
b. Key factors that are driving the personal mobility devices market growth include an increase in disability cases, increasing product development, and growth in the number of accidents causing impairment of the limbs.
b. The wheelchair segment, consisting of manual and powered versions, accounted for the largest share of more than 41.2% in terms of revenue, in the personal mobility devices market in 2021.
b. The rollators segment is expected to witness healthy demand in the personal mobility devices market, owing to the presence of advanced features in the product, as well as rising consumer disposable income.
b. In September 2020, Rollz introduced Parkinson’s rollators for individuals suffering from freezing symptoms associated with Parkinson’s disease.
b. Initiatives such as the Scheme of Assistance to Disabled Persons for Purchase/Fitting of Aids/Appliances (ADIP Scheme) in India, as well as R&D investments initiated by the China Rehabilitation Research Center (CRRC), have strengthened the positive outlook of the personal mobility devices market.
b. The Asia Pacific regional market is expected to witness the fastest growth during the forecast period, owing to the rising geriatric population in the region and increasing disposable income levels of the consumers.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.